Entering text into the input field will update the search result below

Atreca spikes as H.C. Wainwright welcomes updated data for cancer drug

Mar. 04, 2022 11:00 AM ETAtreca, Inc. (BCEL)MRKBy: Dulan Lokuwithana, SA News Editor1 Comment

Human Cancer Cell

luismmolina/E+ via Getty Images

The shares of micro-cap biotech, Atreca (BCEL +46.1%) have added more than a third in morning hours on Friday after the company updated early-stage data for its lead cancer candidate ATRC-101 with its Q4

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.